HMOX1 Attenuates the Sensitivity of Hepatocellular Carcinoma Cells to Sorafenib via Modulating the Expression of ABC Transporters

Hepatocellular carcinoma (HCC) represents a common malignancy, and mechanisms of acquired sorafenib resistance during the treatment of HCC patients remain elusive. The present study performed integrated bioinformatics analysis and explored the potential action of heme oxygenase 1 (HMOX1) in sorafeni...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Xian, Zhang, Yinfang, Wu, Yafei, Diao, Wenjing, Deng, Guilong, Li, Qin, Wu, Chuanxing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9253870/
https://www.ncbi.nlm.nih.gov/pubmed/35800617
http://dx.doi.org/10.1155/2022/9451557

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9253870/
https://www.ncbi.nlm.nih.gov/pubmed/35800617
http://dx.doi.org/10.1155/2022/9451557

Ejemplares similares